Orchard Therapeutics - U.S. Alternatives & Competitors
12 companies similar to Orchard Therapeutics - U.S. — Dedicated to transforming the lives of patients with severe and other genetic di...
Companies similar to Orchard Therapeutics - U.S.
bluebird bio
Pursuing curative gene therapies to give patients and their families more bluebird days.
Somerville, United States
Jasper Therapeutics
Jasper is a biotechnology company focused on targeting mast cells and stem cells to treat...
Redwood City, United Stat...
United Kingdom
Rocket Pharmaceuticals
Seeking gene therapy cures
Cranbury, United States
Track all Orchard Therapeutics - U.S. competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
BlueRock Therapeutics
Striving to transform the treatment of disease by harnessing the power of cell therapy
Cambridge, United States
AAVantgarde
Pioneering treatments for Stargardt disease and Usher 1B, addressing the root cause of the...
Emmaus Life Sciences, Inc
Improving the lives of people with rare disease.
Torrance, United States
Garuda Therapeutics
Creating off-the-shelf, long-term durable blood stem cell therapies
Cambridge, United States
Genenta Science (Nasdaq: GNTA)
Genenta is a clinical stage immuno-oncology company
Milan, Italy
AVROBIO
Clinical-stage lentiviral gene therapy company, powered by plato®. Our vision: bring perso...
Cambridge, United States
Imara
Pioneering therapeutic advancements with innovative solutions for rare genetic hemoglobin...
Immusoft
Cell therapy company dedicated to improving the lives of patients with rare diseases
Seattle, United States
About Orchard Therapeutics - U.S.
Orchard Therapeutics - U.S., established in 2015, stands as a pioneering force in the Biotechnology and Health Care sectors. As a subsidiary of Kyowa Kirin, it is devoted to transforming lives through innovative gene therapy, particularly targeting severe genetic diseases. Their approach involves the genetic modificati...
Development of HSC Gene Therapy, Research and Application of Gene Therapy in Genetic Diseases, Patient-centric Therapeutic Solutions
Families with Members Affected by Genetic Diseases, Healthcare Professionals, Medical Institutions, Researchers in Medical and Genetic Fields
Gene Therapy, Hematopoietic Stem Cell Therapy, Autologous Ex Vivo Therapy, Rare Genetic Diseases, Severe Diseases, Strimvelis, Metachromatic Leukodystrophy, Wiskott-Aldrich Syndrome, Adenosine Deaminase Severe Combined Immunodeficiency, X-linked Chronic Granulomatous Disease, Beta-thalassemia, Clinical Research, Commercial-stage Biotech, Partnerships With Academic Institutions, Curative Treatments
B2B, B2C, B2D
Product Sales, Service Fee, Value Based Pricing
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Orchard Therapeutics - U.S. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Orchard Therapeutics - U.S. on 11 Mar 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
